Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
McKinsey
Fish and Richardson
Chubb
Moodys
Accenture
Covington
Novartis
Harvard Business School
Express Scripts

Generated: January 18, 2018

DrugPatentWatch Database Preview

DEXMEDETOMIDINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Dexmedetomidine Hydrochloride, and when can generic versions of Dexmedetomidine Hydrochloride launch?

Dexmedetomidine Hydrochloride is a drug marketed by Accord Hlthcare, Actavis Inc, Akorn Inc, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Jiangsu Hengrui Med, Luitpold Pharms Inc, Mylan Institutional, Par Sterile Products, Sandoz Inc, Sun Pharm Inds Inc, West-ward Pharms Int, and Hq Spclt Pharma. and is included in thirteen NDAs.

The generic ingredient in DEXMEDETOMIDINE HYDROCHLORIDE is dexmedetomidine hydrochloride. There are thirteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dexmedetomidine hydrochloride profile page.
Drug patent expirations by year for DEXMEDETOMIDINE HYDROCHLORIDE
Pharmacology for DEXMEDETOMIDINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DEXMEDETOMIDINE HYDROCHLORIDE

US Patents and Regulatory Information for DEXMEDETOMIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride INJECTABLE;INJECTION 204023-001 Feb 9, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold Pharms Inc DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride INJECTABLE;INJECTION 203773-001 May 12, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride INJECTABLE;INJECTION 205867-001 Mar 17, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride INJECTABLE;INJECTION 205046-001 Apr 26, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Institutional DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride INJECTABLE;INJECTION 202881-001 Aug 18, 2014 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hq Spclt Pharma DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride SOLUTION;IV (INFUSION) 206628-001 Oct 21, 2015 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Inc DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride INJECTABLE;INJECTION 204686-001 Oct 17, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn Inc DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride INJECTABLE;INJECTION 202585-001 Nov 24, 2014 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jiangsu Hengrui Med DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride INJECTABLE;INJECTION 209065-001 Sep 19, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa DEXMEDETOMIDINE HYDROCHLORIDE dexmedetomidine hydrochloride INJECTABLE;INJECTION 201072-001 Sep 18, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Cantor Fitzgerald
Deloitte
Medtronic
AstraZeneca
Julphar
Moodys
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot